Skin cancer in transplant recipients

The Lancet

Volumn 346, Issue 8980, 1995, Pages 964-965

  McGregor, JaneM ^a   Proby, CharlotteM ^b   Bouwes Bavinck, J N ^c   Vermeer, B J ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; HLA DR ANTIGEN; RETINOID;

AGE; CANCER INCIDENCE; CANCER RISK; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; PAPILLOMA VIRUS; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE;

EID: 0029093067     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91584-2     Document Type: Letter

References (10)

1. Cancer risk after transplantation in the Nordic countries 1964-1986
2. Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management
3. Incidence of skin cancer after renal transplantation in the Netherlands
4. Skin cancer morbidity amongst renal allograft recipients—a 25 year retrospective follow-up study
5. Sunshine and skin cancer: consensus statement
6. Incidence of skin cancer after renal transplantation in the Netherlands
7. Relation between skin cancer and HLA antigens in renal-transplant recipients
8. Skin cancer and renal transplantation
9. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients
10. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal-transplant recipients: a double blind, placebo-controlled study